Bicycle Therapeutics plc ADR (BCYC)
NASDAQ: BCYCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BCYC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $261.07M
- EPS (TTM)
- -$2.73
- Dividend yield
- None
- 52-week range
- 3.33 – 9.16
- Day range
- 3.68 – 3.81
- Volume / Avg
- 472.23K / 389.74K
- Beta
- —
- Shares outstanding
- 50.55M
- Next earnings
- Oct 29, 2026
52-week range
BCYC stock today
On Oct 7, BCYC ended the session at $3.73, shedding $0.06 (1.58%), versus the S&P 500's 0.22% decline. Shares are 59.3% below their 52-week high of $9.16, set on Oct 9, 2025 and 12.0% above the 52-week low of $3.33, near the bottom of the past year's range. BCYC is down 47.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 53.4%.
Bicycle Therapeutics has posted a net loss over the last twelve months (EPS of -$2.73), so its P/E ratio is not meaningful. Bicycle Therapeutics's next earnings report is expected on Oct 29, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Bicycle Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2019
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $-0.30
BCYC news
All BCYC newsBicycle Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACIUAC Immune SA | 2.57 | +1.98% | $255.53M | vs BCYC |
| VNDAVanda Pharmaceuticals Inc. | 4.56 | +0.89% | $275.71M | vs BCYC |
| BBOTBridgeBio Oncology Therapeutics Inc. | 3.44 | -1.71% | $275.80M | vs BCYC |
| AMRNAmarin Corporation plc | 12.02 | -0.41% | $253.90M | vs BCYC |
| UPBUpstream Bio Inc. | 4.61 | +0.44% | $252.49M | vs BCYC |
| RCKTRocket Pharmaceuticals Inc. | 2.54 | +2.22% | $278.28M | vs BCYC |
| FULCFulcrum Therapeutics Inc. | 3.67 | -0.54% | $280.01M | vs BCYC |
| ZNTLZentalis Pharmaceuticals Inc. | 2.55 | -4.49% | $250.21M | vs BCYC |
Indexes, lists and sector
Bicycle Therapeutics stock FAQ
What is Bicycle Therapeutics's stock price today?
BCYC last traded at $3.73 as of Oct 7, 4:00 PM EDT, down 1.58% on the day. Prices are delayed at least 15 minutes.
When is Bicycle Therapeutics's next earnings date?
Bicycle Therapeutics is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $-0.30.
What is the BCYC 52-week high?
The 52-week high for BCYC is $9.16 and the 52-week low is $3.33. The stock is currently 59.3% below its high.